Back to search

Article

TERT promoter mutation predicts the prognosis value of patients with HBV- related HCC who underwent hepatectomy

2022-11-07

Abstract excerpt

<h4>Background and Aims: </h4> Recurrence is the major cause of poor prognosis in hepatocellular carcinoma (HCC), especially in those infected with HBV. Telomerase reverse transcriptase (TERT) promoter is the most prevalent site in HBV-related HCC. We attempted to evaluate the prognostic value of TERT mutation status in HBV-related HCC patients. <h4>Methods: </h4> We enrolled the 66 HBV-related HCC patients who un...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
1d2defa2-903e-5a32-a859-f631db1488c1
DOI
10.21203/rs.3.rs-2237837/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
TERT promoter mutation predicts the prognosis value of patients with HBV- related HCC who underwent hepatectomyDOI 10.21203/rs.3.rs-2237837/v1
Select a neighboring publication to make it the new centre.